Polymorphonuclear leukocyte 5-lipoxygenase activity in psoriasis.

Area of Science:

• Biochemistry
• Immunology
• Dermatology

Background:

• Psoriasis is a chronic inflammatory skin disease characterized by hyperproliferation.
• Arachidonic acid metabolites, specifically those from the 5-lipoxygenase pathway, are suspected contributors to psoriasis pathophysiology.
• Investigating extracutaneous tissues is crucial to understand systemic involvement in psoriasis.

Purpose of the Study:

• To determine if the 5-lipoxygenase pathway is activated in circulating polymorphonuclear leukocytes in patients with psoriasis.
• To compare the activity of this pathway in psoriatic patients versus healthy controls.

Main Methods:

• Polymorphonuclear leukocytes were isolated from both psoriatic patients and control subjects.
• The conversion rate of 14C-arachidonic acid was measured in these leukocytes.
• Key 5-lipoxygenase products, leukotriene B4 and 5-hydroxyeicosatetraenoic acid, were quantified.

Main Results:

• There was no statistically significant difference in the production of leukotriene B4 between psoriatic and control groups.
• Similarly, the generation of 5-hydroxyeicosatetraenoic acid by polymorphonuclear leukocytes did not differ significantly between the two groups.
• These findings indicate comparable 5-lipoxygenase pathway activity in circulating white blood cells.

Conclusions:

• The study concludes that the 5-lipoxygenase pathway is not enhanced in circulating polymorphonuclear leukocytes in patients with psoriasis.
• This suggests that the role of this specific pathway in systemic inflammation associated with psoriasis may be limited to cutaneous tissues or other cell types.
• Further research is needed to explore other inflammatory pathways or cellular components in psoriasis.